![](/img/cover-not-exists.png)
The impact of oral anticoagulant therapy, factor VIII level and quality of factor V-deficient plasma on three commercial methods for activated protein C resistance
Chitolie, A., Lawrie, A. S., Mackie, I. J., Harrison, P., Machin, S. J.Volume:
12
Language:
english
Journal:
Blood Coagulation and Fibrinolysis
DOI:
10.1097/00001721-200104000-00003
Date:
April, 2001
File:
PDF, 160 KB
english, 2001